Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Ono

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 10, 2018
[Economic Evaluation of mFOLFOX6-based First-line Regimens for Unresectable Advanced or Recurrent Colorectal Cancer Using Clinical Decision Analysis]Toshihiro Shida, Yuji Endo, Tadashi Shiraishi, et al.
Surgical Case Reports|October 14, 2022
Surgical resection of a tuberculoma in the diaphragm: a case reportAsato Hashinokuchi, Mikihiro Kohno, Keisuke Kosai, et al.
Journal of Biomolecular NMR|July 31, 2017
Protein <sup>19</sup>F-labeling using transglutaminase for the NMR study of intermolecular interactionsYoshikazu Hattori, David Heidenreich, Yuki Ono, et al.
Plos One|January 20, 2023
Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channelsManae Tatsumi, Takayuki Kishi, Satoru Ishida, et al.
International Cancer Conference Journal|January 25, 2021
First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with <i>EGFR</i> mutation as the initial and solitary site of postoperative recurrenceYuki Ono, Kazuki Takada, Atsushi Osoegawa, et al.
Anticancer Research|January 30, 2022
Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung AdenocarcinomaTomoyoshi Takenaka, Tetsuzo Tagawa, Mikihiro Kohno, et al.
Translational Cancer Research|February 4, 2022
Long-term complete response to gefitinib after treatment termination in a patient with recurrent post-operative <i>EGFR</i>-mutated lung adenocarcinoma: case report and literature reviewKenji Watanabe, Naoki Haratake, Tomoyoshi Takenaka, et al.
Cellular Signalling|August 1, 2018
The LPA<sub>2</sub> receptor agonist Radioprotectin-1 spares Lgr5-positive intestinal stem cells from radiation injury in murine enteroidsBryan Kuo, Erzsébet Szabó, Sue Chin Lee, et al.
Nature Communications|January 26, 2022
Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer biasKouki Kawakami, Masataka Yanagawa, Suzune Hiratsuka, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 4, 2018
Comparison of USA300 with non-USA300 methicillin-resistant Staphylococcus aureus in a neonatal intensive care unitTakemi Murai, Kaoru Okazaki, Kazue Kinoshita, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 10, 2018
[Economic Evaluation of mFOLFOX6-based First-line Regimens for Unresectable Advanced or Recurrent Colorectal Cancer Using Clinical Decision Analysis]Toshihiro Shida, Yuji Endo, Tadashi Shiraishi, et al.
Surgical Case Reports|October 14, 2022
Surgical resection of a tuberculoma in the diaphragm: a case reportAsato Hashinokuchi, Mikihiro Kohno, Keisuke Kosai, et al.
Journal of Biomolecular NMR|July 31, 2017
Protein <sup>19</sup>F-labeling using transglutaminase for the NMR study of intermolecular interactionsYoshikazu Hattori, David Heidenreich, Yuki Ono, et al.
Plos One|January 20, 2023
Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channelsManae Tatsumi, Takayuki Kishi, Satoru Ishida, et al.
International Cancer Conference Journal|January 25, 2021
First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with <i>EGFR</i> mutation as the initial and solitary site of postoperative recurrenceYuki Ono, Kazuki Takada, Atsushi Osoegawa, et al.
Anticancer Research|January 30, 2022
Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung AdenocarcinomaTomoyoshi Takenaka, Tetsuzo Tagawa, Mikihiro Kohno, et al.
Translational Cancer Research|February 4, 2022
Long-term complete response to gefitinib after treatment termination in a patient with recurrent post-operative <i>EGFR</i>-mutated lung adenocarcinoma: case report and literature reviewKenji Watanabe, Naoki Haratake, Tomoyoshi Takenaka, et al.
Cellular Signalling|August 1, 2018
The LPA<sub>2</sub> receptor agonist Radioprotectin-1 spares Lgr5-positive intestinal stem cells from radiation injury in murine enteroidsBryan Kuo, Erzsébet Szabó, Sue Chin Lee, et al.
Nature Communications|January 26, 2022
Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer biasKouki Kawakami, Masataka Yanagawa, Suzune Hiratsuka, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 4, 2018
Comparison of USA300 with non-USA300 methicillin-resistant Staphylococcus aureus in a neonatal intensive care unitTakemi Murai, Kaoru Okazaki, Kazue Kinoshita, et al.
Pageof 7